MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.

Bioengineered
Huiming ZhangGang Zhao

Abstract

Our study seeks to obtain data which help to assess the impacts and related mechanisms of microRNA miR-509-3p in hepatocellular carcinoma (HCC). We found that the expression of miR-509-3p was down-regulated and Twist was up-regulated in HCC tissues and cell lines (HepG2, HCCLM3, Bel7402, and SMMC7721) compared with the adjacent normal tissues and normal human hepatocyte (L02). Moreover, cell proliferation, invasion, migration and epithelial-mesenchymal transition (EMT) in HepG2 and HCCLM3 cells were appeared to be markedly suppressed by overexpressed miR-509-3p. Overexpression of miR-509-3p also performed inhibition of the growth and metastasis in vivo. In addition, miR-509-3p could target and inhibit Twist expression, and it could further reverse the tumor promotion by Twist in HCC. All in all, miR-509-3p overexpression causes inhibition of the proliferation, migration, invasion and EMT of HCC cells by negatively regulating Twist, thereby suppressing HCC development and metastasis.

References

Sep 17, 2004·Nature·Victor Ambros
Mar 22, 2006·Current Opinion in Gastroenterology·Jorge A Marrero
Dec 8, 2007·Biochemical and Biophysical Research Communications·Farhad VesunaVenu Raman
Aug 12, 2008·Biochemical and Biophysical Research Communications·Cliff Ji-Fan LinJen-Leih Wu
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jul 13, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tao SunZhi-yong Liu
Dec 14, 2011·Cell·Maria HatziapostolouDimitrios Iliopoulos
Oct 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvia Giordano, Amedeo Columbano
Nov 14, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Angela Gauthier, Mitchell Ho
Feb 13, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hao YangLianyue Yang
Jul 24, 2013·Journal of Gastroenterology and Hepatology·Hongyang Wang, Lei Chen
Nov 12, 2013·Biochemical and Biophysical Research Communications·Yanxin LuKeWei Wang
May 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rui-Min ChangLian-Yue Yang
Jul 17, 2014·Trends in Molecular Medicine·Josie HayesSean Lawler
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Oct 17, 2015·Annual Review of Medicine·Andrea MarengoElisabetta Bugianesi
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Jan 24, 2018·Biochemical and Biophysical Research Communications·Shengni HuaDehua Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.